Renaissance Technologies Llc ownership in ASRT / Assertio Holdings, Inc.

Assertio Holdings, Inc.

US ˙ NasdaqCM

Security	ASRT / Assertio Holdings, Inc.
Institution	Renaissance Technologies Llc
Manager	James Simons
Latest Disclosed Ownership	12,800 shares
Ownership	0.03%

2022-02-10 - Renaissance Technologies Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,800 shares of Assertio Holdings, Inc. (US:ASRT). This represents 0.03 percent ownership of the company. In their previous filing dated 2021-02-11 , Renaissance Technologies Llc had reported owning 6,522,314 shares, indicating a decrease of -99.80 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2022-02-10	2022-02-10	13G/A	6,522,314	12,800	-99.80	0.03	-99.51
2021-02-11	2021-02-11	13G/A	6,529,527	6,522,314	-0.11	6.08	-24.85
2020-02-13	2020-02-13	13G/A	4,668,591	6,529,527	39.86	8.09	10.82
2019-02-12	2019-02-12	13G		4,668,591		7.30
2019-02-12	2019-02-12	13G		4,668,591		7.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-14	2026-03-31	13F	ASSERTIO HOLDINGS	COM NEW	04546C304	228,599	37,902	19.88	4,357	152.00	0.0068
2026-02-12	2025-12-31	13F	ASSERTIO HOLDINGS	COM NEW	04546C304	190,697	-6,064,835	-96.95	1,730	-57.48	0.0027
2020-05-14	2020-03-31	13F	ASSERTIO THERAPEUTICS	COM	04545L107	6,255,532	-273,995	-4.20	4,066	-50.18	0.0039
2020-02-13	2019-12-31	13F	ASSERTIO THERAPEUTICS	COM	04545L107	6,529,527	803,238	14.03	8,162	11.35	0.0063
2019-11-13	2019-09-30	13F	ASSERTIO THERAPEUTICS	COM	04545L107	5,726,289	637,600	12.53	7,330	-58.25	0.0062
2019-08-12	2019-06-30	13F	ASSERTIO THERAPEUTICS	COM	04545L107	5,088,689	-92,738	-1.79	17,556	-33.17	0.0155
2019-05-14	2019-03-31	13F	ASSERTIO THERAPEUTICS	COM	04545L107	5,181,427	512,836	10.98	26,270	55.87	0.0239
2019-02-12	2018-12-31	13F	ASSERTIO THERAPEUTICS	COM	04545L107	4,668,591	312,853	7.18	16,854	-34.19	0.0185
2018-11-13	2018-09-30	13F	ASSERTIO THERAPEUTICS	COM	04545L107	4,355,738	-211,700	-4.63	25,612	-15.93	0.0263
2018-08-13	2018-06-30	13F/A-1	DEPOMED	COM	249908104	4,567,438	888,300	24.14	30,465	25.65	0.0332
2018-08-13	2018-06-30	13F	DEPOMED	COM	249908104	3,679,138			24,246
2018-05-14	2018-03-31	13F	DEPOMED	COM	249908104	3,679,138	955,738	35.09	24,246	10.60	0.0265
2018-02-13	2017-12-31	13F	DEPOMED	COM	249908104	2,723,400	1,704,200	167.21	21,923	271.51	0.0242
2017-11-13	2017-09-30	13F	DEPOMED	COM	249908104	1,019,200	820,762	413.61	5,901	176.91	0.0069
2017-08-11	2017-06-30	13F	DEPOMED	COM	249908104	198,438	-20,000	-9.16	2,131	-22.25	0.0027
2017-05-12	2017-03-31	13F	DEPOMED	COM	249908104	218,438	218,438		2,741		0.0038
2016-02-11	2015-12-31	13F	DEPOMED	COM	249908104	0	-104,146	-100.00	0	-100.00
2015-11-12	2015-09-30	13F	DEPOMED	COM	249908104	104,146	-25,192	-19.48	1,963	43.49	0.0047
2014-02-14	2013-12-31	13F	DEPOMED	COM	249908104	129,338	129,338		1,368		0.0033

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.